These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25531655)

  • 1. The effect of metformin on cardiac fibrosis via differentiation of cardiac fibroblasts.
    Ünlü M; Balta Ş; Arslan Z; Öztürk C; Çelik T; Iyisoy A
    Cardiology; 2015; 130(1):52-3. PubMed ID: 25531655
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to the paper by Ünlü et al. entitled 'The effect of metformin on cardiac fibrosis via differentiation of cardiac fibroblasts'.
    Li J; Song SJ
    Cardiology; 2015; 130(1):54. PubMed ID: 25531774
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating percutaneous coronary intervention-related myocardial injury with metformin.
    Calvert JW
    Cardiology; 2014; 127(2):130-2. PubMed ID: 24335004
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of metformin on myocardial tolerance to ischemia in rats with diabetes mellitus type 2].
    Kravchuk EN; Grineva EN; Galagudza MM; Bairamov AA
    Patol Fiziol Eksp Ter; 2013; (4):32-4. PubMed ID: 24640771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention.
    Li J; Xu JP; Zhao XZ; Sun XJ; Xu ZW; Song SJ
    Cardiology; 2014; 127(2):133-9. PubMed ID: 24335026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardioprotective effects of metformin.
    El Messaoudi S; Rongen GA; de Boer RA; Riksen NP
    Curr Opin Lipidol; 2011 Dec; 22(6):445-53. PubMed ID: 21897229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin and myocardial ischemia-reperfusion injury.
    Hu J; Lu Y
    Int J Cardiol; 2016 Nov; 222():988. PubMed ID: 27526377
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury.
    Kharbanda RK
    Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460
    [No Abstract]   [Full Text] [Related]  

  • 9. Remifentanil and opioid-induced cardioprotection.
    Irwin MG; Wong GT
    J Cardiothorac Vasc Anesth; 2015 Jun; 29 Suppl 1():S23-6. PubMed ID: 26025042
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial protection from ischemia-reperfusion injury post coronary revascularization.
    Binder A; Ali A; Chawla R; Aziz HA; Abbate A; Jovin IS
    Expert Rev Cardiovasc Ther; 2015; 13(9):1045-57. PubMed ID: 26202544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trimetazidine, oxidative stress, and cell injury during myocardial reperfusion].
    Ruiz-Meana M
    Rev Esp Cardiol; 2005 Aug; 58(8):895-7. PubMed ID: 16053822
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative analysis of early and delayed cardioprotective and antiarrhythmic efficacy of hypoxic preconditioning.
    Maslov LN; Lishmanov YB; Krylatov AV; Sementsov AS; Portnichenko AG; Podoksenov YK; Khaliulin IG
    Bull Exp Biol Med; 2014 Apr; 156(6):746-9. PubMed ID: 24824686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does growth differentiation factor 11 protect against myocardial ischaemia/reperfusion injury? A hypothesis.
    Yang Y; Yang Y; Wang X; Du J; Hou J; Feng J; Tian Y; He L; Li X; Pei H
    J Int Med Res; 2017 Dec; 45(6):1629-1635. PubMed ID: 27565745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QiShenYiQi Pills® prevent cardiac ischemia-reperfusion injury via energy modulation.
    Lin SQ; Wei XH; Huang P; Liu YY; Zhao N; Li Q; Pan CS; Hu BH; Chang X; Fan JY; Yang XY; Wang CS; Liu HN; Han JY
    Int J Cardiol; 2013 Sep; 168(2):967-74. PubMed ID: 23168012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising strategies to minimize reperfusion injury in STEMI.
    Bulluck H; Yellon RL; Yellon DM
    Minerva Cardioangiol; 2016 Jun; 64(3):284-94. PubMed ID: 26859232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial overview: cardioprotective drugs for myocardial ischemic injury--a therapeutic area at risk.
    Knight DR
    Curr Opin Investig Drugs; 2007 Mar; 8(3):190-2. PubMed ID: 17408113
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac pre- and post-conditioning: implications in anesthesia?
    Pesonen E
    Acta Anaesthesiol Scand; 2010 Aug; 54(7):793-4. PubMed ID: 20649515
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaesthesia and myocardial ischaemia/reperfusion injury.
    Frässdorf J; De Hert S; Schlack W
    Br J Anaesth; 2009 Jul; 103(1):89-98. PubMed ID: 19502287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.
    Whittington HJ; Hall AR; McLaughlin CP; Hausenloy DJ; Yellon DM; Mocanu MM
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):5-16. PubMed ID: 23192487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size.
    Roesner JP; Mersmann J; Bergt S; Bohnenberg K; Barthuber C; Szabo C; Nöldge-Schomburg GE; Zacharowski K
    Shock; 2010 May; 33(5):507-12. PubMed ID: 20395771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.